why choose us

First received: January 13, 2023

Clinical Trial: TSI and Its Relationship With Graves' Disease Relapse

Study Status: Completed

Recruit Status: Completed

Condition: Graves Disease
Immunoglobulin
Anti-Thyroid Antibodies Disorder

Study Type: Observational


Official Title: Thyroid-stimulating Immunoglobulins Level in Patients With Graves' Disease Undergoing Maintenance-dose of Antithyroid Drug and Its Relationship With Disease Relapse

Brief Summary: The goal of this observational study is to determine the role of TSI, as well as clinical signs and thyroid function tests in predicting Graves' disease (GD) relapse after withdrawing anti thyroid drug (ATD). The main questions it aims to answer are:To investigate the serum TSI concentration in patients with GD undergoing maintenance-dose ATD.To determine an optimal cut-off of TSI level for predicting GD relapse.To determine the role of TSI in predicting Graves' disease relapse after withdrawing ATD.

Read more